Zuheer Meeraalam

Zuheer Meeraalam

Auto-generated profile, based on publicly available information

Zuheer Meeraalam

Ophthalmology Department, Prince Sultan Military Medical City, Riyadh, Saudi Arabia

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2025 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
ZMZuheer Meeraalam
Zuheer Meeraalam
SAShaker Alreshidi
Shaker Alreshidi
HAHani Albalawi
Hani Albalawi
NANaif M Alali
Naif M Alali
FHFaris Hashem
Faris Hashem
OKOmar M Kirat
Omar M Kirat
Background: Corneal transplantation is a critical procedure for restoring vision affected by different corneal pathologies. However, postoperative infections threaten graft survival, particularly microbial keratitis and endophthalmitis. Objective: This study aims to evaluate the incidence of culture-positive corneoscleral rims (CPCR) among transplanted corneas at a tertiary eye hospital and explore its association with death-preservation and preservation-surgery times. Methods: A retrospective analysis of keratoplasty surgeries performed in 2015 was conducted, involving 603 cases meeting the study criteria. Results: The incidence of CPCR was found to be 4.6%, predominantly bacterial (68%), with Methicillin-resistant Staphylococcus epidermidis (MRSE) being the most common isolate, followed by fungal (32%) species, notably Candida. However, none of the cases developed subsequent keratitis or endophthalmitis post-transplantation. Statistical analysis revealed no significant association between CPCR occurrence and death-preservation or preservation-surgery times. Conclusion: The study underscores the reduced impact of contaminated CPCR on graft outcomes, advocating for targeted fungal culturing, intraoperative practices to mitigate post-transplant infections, and maintaining current prophylactic antibiotic regimens, such as optisolGS ™, which contains streptomycin and gentamicin.